Presentations are our most important and direct means of communicating with the public. Our goal is to share our exploration and insights into bioimaging technology with a wider audience both within and outside the field of synthetic biology, while also promoting and popularizing our research findings. We strive to foster a deeper understanding and thought about biotechnology in society and to bring innovative technological achievements to humanity.
On September 8, 2024, we held a joint presentation event with four other iGEM teams from our university: Jilin-China, JLU-CP, CJUH-JLU-China, and JLU-NBBMS. This event attracted students from various colleges and grades at Jilin University.
</p>
...
...
@@ -104,9 +104,12 @@
<p>
We interviewed various iGEM teams, including Peking-HSC from Peking University and CPU-China from China Pharmaceutical University. Our goal was to explore the research projects of different teams, investigate diverse approaches to Human Practice, and reflect on the significance of synthetic biology for humanity and society. This initiative aims to facilitate effective communication between teams. Additionally, we edited and published these interviews on different platforms to directly educate and promote our findings to the public.
This summer, we participated in two major conferences: the 11th CCiC (Conference of China iGEMer Community) and the 1st Northeast iGEMer Meetup. The public presentations at these conferences were of significant importance to us, as they not only presented the challenge of clearly and systematically showcasing our research achievements but also provided us with a platform for communication and learning. At these conferences, we discussed the principles, applications, and significance of the bioimaging technology developed by our team, while also listening to the projects and innovations from other teams and engaging in exchanges with them. Through our shared passion for synthetic biology, we built a community that created opportunities for further understanding and communication.
</p>
<h4><b>11th CCiC (Conference of China iGEMer Community)</b></h4>
<p><b>11th CCiC (Conference of China iGEMer Community)</b></p>
<p>
From July 11 to 14, 2024, we traveled to Xi'an Jiaotong-Liverpool University to attend the 11th CCiC. This year's conference was themed "SynBio Nexus," with 89 college teams and 35 high school teams participating.
On August 12, 2024, we attended the 1st Northeast iGEMer Meetup at Northeast Normal University. Primarily featuring iGEM teams from Northeast China, the conference invited 12 iGEM teams from universities and high schools both domestically and internationally, aiming to establish a platform for showcasing and discussing the key role of synthetic biology in addressing global challenges.
</p>
...
...
@@ -192,7 +195,7 @@
<p>
This summer, we engaged in discussions with several biotechnology companies in Beijing. These visits and communications with biotech firms were crucial for us as we transformed the technologies we developed into products and established a comprehensive business plan and model. Therefore, we needed to build effective communication channels with these companies, conduct thorough site visits and project discussions, understand the current state of research and production in synthetic biology companies, and explore the technological applications and market conversion of synthetic biology. This would help us assess the feasibility and prospects of our plans.
</p>
<h4><b>Acrobiosystems Co., Ltd</b></h4>
<p><b>Acrobiosystems Co., Ltd</b></p>
<p>
On July 15, 2024, we visited ACRO Biosystems Co., Ltd. ACRO Biosystems Group is a cornerstone enterprise providing key biological reagent products and solutions for the global biopharmaceutical and health industry.
On July 16, 2024, we, together with the Peking-HSC team from Peking University, visited Beijing Chuangmu Biotechnology (Beijing) Co., Ltd., where we had a discussion with Mr. Kang Kai, the company's founder and executive vice president.
